PMID- 32590698 OWN - NLM STAT- MEDLINE DCOM- 20211215 LR - 20211215 IS - 1540-0514 (Electronic) IS - 1073-2322 (Linking) VI - 55 IP - 1 DP - 2021 Jan 1 TI - STEMI, Cardiogenic Shock, and Mortality in Patients Admitted for Acute Angiography: Associations and Predictions from Plasma Proteome Data. PG - 41-47 LID - 10.1097/SHK.0000000000001595 [doi] AB - AIM: Acute myocardial infarction (AMI) remains a major cause of mortality and morbidity, and cardiogenic shock (CS) a major cause of hospital mortality after AMI. Especially for ST elevation myocardial infarction (STEMI) patients, fast intervention is essential.Few proteins have proven clinically applicable for AMI. Most proposed biomarkers are based on a priori hypothesis-driven studies of single proteins, not enabling identification of novel candidates. For clinical use, the ability to predict AMI is important; however, studies of proteins in prediction models are surprisingly scarce.Consequently, we applied proteome data for identifying proteins associated with definitive STEMI, CS, and all-cause mortality after admission, and examined the ability of the proteins to predict these outcomes. METHODS AND RESULTS: Proteome-wide data of 497 patients with suspected STEMI were investigated; 381 patients were diagnosed with STEMI, 35 with CS, and 51 died during the first year. Data analysis was conducted by logistic and Cox regression modeling for association analysis, and by multivariable LASSO regression models for prediction modeling.Association studies identified 4 and 29 proteins associated with definitive STEMI or mortality, respectively. Prediction models for CS and mortality (holding two and five proteins, respectively) improved the prediction ability as compared with protein-free prediction models; AUC of 0.92 and 0.89, respectively. CONCLUSION: The association analyses propose individual proteins as putative protein biomarkers for definitive STEMI and survival after suspected STEMI, while the prediction models put forward sets of proteins with putative predicting ability of CS and survival. These proteins may be verified as biomarkers of potential clinical relevance. CI - Copyright (c) 2020 by the Shock Society. FAU - Debrabant, Birgit AU - Debrabant B AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. FAU - Halekoh, Ulrich AU - Halekoh U AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. FAU - Soerensen, Mette AU - Soerensen M AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. AD - Center for Individualized Medicine in Arterial Diseases, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark. AD - Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. FAU - Moller, Jacob Eifer AU - Moller JE AD - Department of Clinical Cardiology, Odense University Hospital, Odense C, Denmark. AD - Department of Cardiology, Rigshospitalet and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. FAU - Hassager, Christian AU - Hassager C AD - Department of Cardiology, Rigshospitalet and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. FAU - Frydland, Martin AU - Frydland M AD - Department of Cardiology, Rigshospitalet and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. FAU - Palstrom, Nicolai AU - Palstrom N AD - Center for Individualized Medicine in Arterial Diseases, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark. FAU - Hjelmborg, Jacob AU - Hjelmborg J AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. FAU - Beck, Hans Christian AU - Beck HC AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. AD - Center for Individualized Medicine in Arterial Diseases, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark. FAU - Rasmussen, Lars Melholt AU - Rasmussen LM AD - Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense C, Denmark. AD - Center for Individualized Medicine in Arterial Diseases, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Shock JT - Shock (Augusta, Ga.) JID - 9421564 RN - 0 (Biomarkers) RN - 0 (Blood Proteins) RN - 0 (Proteome) SB - IM MH - Aged MH - Biomarkers/metabolism MH - Blood Proteins/*genetics/metabolism MH - Coronary Angiography MH - Female MH - Hospital Mortality MH - Hospitalization MH - Humans MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Proportional Hazards Models MH - *Proteome MH - ST Elevation Myocardial Infarction/*blood/diagnosis/*mortality MH - Shock, Cardiogenic/*blood/diagnosis/*mortality MH - Survival Rate COIS- The authors report no conflicts of interest. EDAT- 2020/06/27 06:00 MHDA- 2021/12/16 06:00 CRDT- 2020/06/27 06:00 PHST- 2020/06/27 06:00 [pubmed] PHST- 2021/12/16 06:00 [medline] PHST- 2020/06/27 06:00 [entrez] AID - 00024382-202101000-00006 [pii] AID - 10.1097/SHK.0000000000001595 [doi] PST - ppublish SO - Shock. 2021 Jan 1;55(1):41-47. doi: 10.1097/SHK.0000000000001595.